Doppler flowmeter examination.3 The possibility of using a noninvasive procedure to differentiate easily and accurately between ischaemic and nonischaemic testicular lesions is welcomed, and this method should soon become indispensible in cases of acute scrotum; it would certainly help to avoid unnecessary urgent operations in newborn infants and children. When we applied a strict definition of 'simple' febrile convulsions in an attempt to obtain a uniform population, thereby reducing the numbers from 265 to 64, we realised that the small numbers would invite statistical argument. Nevertheless, we maintain that our recommendation that any child below age 18 months who presents with a febrile convulsion should be treated with either phenobarbitone or sodium valproate is validated by our results. We showed that the results for all treated subjects were statistically superior than for the untreated group (P<0 05). The treatment was either phenobarbitone or sodium valproate, administered in a double-blind manner, and the results were similar in the two treatment groups. We agree that the difference between the results in the phenobarbitone and untreated groups is not significant, nor did we claim the contrary. There is strong evidence from previous work (discussed in our article) that phenobarbitone is more effective than nothing, and our trial was designed to discover if sodium valproate was as effective as phenobarbitone. Dr Giles surely has his group.bmj.com on June 20, 2017 -Published by http://adc.bmj.com/ Downloaded from
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